Deterin, a new apoptosis inhibitor from Drosophila melanogaster, possesses
an unusual structure of only a single baculovirus inhibitor of apoptosis (L
AP)-type repeat and no RING finger motif. The biochemical actions of deteri
n are demonstrated in SF9 and S2 cell transfection assays, in which the exp
ressed protein acts in the cytoplasm to inhibit or deter cells from apoptos
is otherwise induced by the caspase-dependent apoptosis activator reaper or
by cytotoxicants, A loss of function phenotype for deterin of cell death w
as indicated by transfections with either a dominant negative deterin mutan
t or with inhibitory RNA (RNAi) for deterin, The dominant negative C-termin
al fragment that antagonized antiapoptotic activity of deterin did not affe
ct antiapoptotic activity of DIAP1 or p35. Both the baculovirus IAP-type re
peat (BIR) domain and the alpha-helical C-terminal domain are necessary in
both SF9 and 52 cells for deterin to manifest its activity to prevent cell
death. The approximately 650-base deterin transcript is present in embryos,
third instar larvae, acid late stage nurse cells of adult females. The det
erin transcript is distributed throughout early stage embryos, whereas in l
ater stage embryos it becomes progressively restricted to the central nervo
us system and gonads. Whereas the nematode survivin-type ZAP has thus far b
een implicated only as a mitotic regulator, Drosophila deterin constitutes
the first invertebrate member of the sunvivin-type IAP group to exhibit apo
ptosis-inhibitory activity.